Ascendis Pharma A (ASND) Net Income (2014 - 2026)
Ascendis Pharma A's Net Income was $240.57 million in the quarter ended Jun 30, 2026, compared with -$43.98 million a year earlier and down 67.3% from the prior quarter.
Powered by 
Analysis
Ascendis Pharma A (ASND) Net Income (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Ascendis Pharma A's Net Income was $867 million through Jun 30, 2026; for the year ended Dec 31, 2025, it was -$257.64 million.
- In earlier years, Net Income was -$409.21 million in the year ended Dec 31, 2024, -$520.79 million in the year ended Dec 31, 2023, -$614.66 million in the year ended Dec 31, 2022 and -$438.8 million in the year ended Dec 31, 2021.
- Quarterly Net Income has moved between -$211.62 million (the quarter ended Dec 31, 2022) and $736.8 million (the quarter ended Mar 31, 2026) over five years.
- Per Business Quant data, ASND's Net Income in the three quarters before the quarter ended Jun 30, 2026 was $736.8 million (quarter ended Mar 31, 2026), -$39.07 million (quarter ended Dec 31, 2025) and -$71.3 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Ascendis Pharma A | 15.06 Bn | 11.32 Bn | 362.22 Mn | 240.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 240.57 Mn |
| Mar 31, 2026 | 736.80 Mn |
| Dec 31, 2025 | -39.07 Mn |
| Sep 30, 2025 | -71.30 Mn |
| Jun 30, 2025 | -43.98 Mn |
| Mar 31, 2025 | -99.54 Mn |
| Dec 31, 2024 | -41.11 Mn |
| Sep 30, 2024 | -108.94 Mn |
| Jun 30, 2024 | -117.79 Mn |
| Mar 31, 2024 | -142.35 Mn |
| Dec 31, 2023 | -93.48 Mn |
| Sep 30, 2023 | -176.59 Mn |
| Jun 30, 2023 | -132.23 Mn |
| Mar 31, 2023 | -119.05 Mn |
| Dec 31, 2022 | -211.62 Mn |
| Sep 30, 2022 | -170.35 Mn |
| Jun 30, 2022 | -86.77 Mn |
| Mar 31, 2022 | -140.85 Mn |
| Dec 31, 2021 | -121.33 Mn |
| Sep 30, 2021 | -94.75 Mn |
API Access
Ascendis Pharma A Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();